The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients

NCT01137799 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
47
Enrollment
INDUSTRY
Sponsor class

Stopped Efficacy signals were insufficiently strong to justify recruitment of additional patients.

Conditions

Interventions

Sponsor

Janssen Pharmaceutica N.V., Belgium